62 Data

indicating that fields of EpCAM-positive hepatocytes are progeny of EpCAM-positive DRs suggest that mutational events may arise in the DR ecotones, paralleling species evolution geographically. Some may be evolutionarily adaptive at the cell population level. For example, mutations in rapidly proliferative and therefore mutationally susceptible hepatobiliary progenitors might lead to emergence of hepatocytes resistant to disease (e.g., resistant to copper accumulation in Wilson’s disease or to lipotoxicity in fatty liver disease). Of course, it also opens the door to deeper, more complex understandings of hepatocarcinogenesis associated with Dorsomorphin chemical structure emergence of DRs. The prevailing concept of liver regeneration is that replenishment of cellular loss is by proliferation of mature cells and that activation of the stem/progenitor cell compartment(s) occur(s) when the proliferative capacity of mature cells is exhausted or MI-503 clinical trial inhibited. The absence of DRs in normal livers supports this. However, a basal activity of the stem cell niche to generate hepatocytes as a regular process of cellular renewal is not excluded, particularly

given the discovery of clonal patches of CoH-derived hepatocytes.30 This maintenance activity does not occur through overt DR, but possibly through “post-natal hepatoblasts” and “peribiliary hepatocytes.”7,23,31 The relative dynamics and contributions of hepatocyte replication versus DRs to parenchymal restitution in chronic liver disease appears to change with time, with increasing proliferation of DR hepatobiliary cells correlating with diminishing hepatocyte replicative

potential and increasing senescence.4,16,18 A recent study of hepatic progenitor cells in HCV found a significant selleck correlation between DRs and older age, which supports the role of senescence.46 That DRs are a source of hepatocellular restoration is most strongly supported by recent studies showing that EpCAM-positive hepatocytes had telomere lengths longer than those of EpCAM-negative hepatocytes (which presumably are older and/or derive from replication of earlier hepatocytes), but slightly shorter than those of the DR cells, which express telomerase.6 Thus, in diseases of all kinds, DRs mediate repair, at least in part, and may reflect activation of multiple stem/progenitor niches. From a tissue biological point of view, the basis of DR success as a prevalent reparative mechanism lies in the “geographic” uniqueness of the niche from which DR arises, the portal–parenchymal interface. Here, interactions between the hepatobiliary cells with portal and periportal mesenchymal cells are likely through both production of diffusible growth controlling factors and physical cell–cell contact. For example, hepatocyte:sinusoidal endothelium contact is instrumental in regeneration.

Therefore, the use of ice where coagulation is already negatively affected may carry more risk than benefit. Physiotherapy intervention is important during all phases surrounding EOS in PWHWI. However, it is crucial that the physiotherapist understand the differences between treating a person in the general population versus PWH and PWHWI to Selleck Doxorubicin promote positive outcomes and a greater benefit than risk to these individuals. S. Rahim In developing countries,

physiotherapy is considered an integral component of the management and prevention of musculoskeletal complications as a result of recurrent joint or muscle bleeds [37]. The gold standard for physiotherapy intervention is for therapy to be performed with adequate factor replacement cover in order to minimize the risk of bleeding during treatment. In the author’s experience, factor cover is preferred in the case of inhibitor patients undergoing physical therapy. However, the inaccessibility of factor or the presence of inhibitors should not prevent

a PWH from accessing physiotherapy. There are various physiotherapy modalities and guidelines that can be utilized in the management of PWH and will be highlighted in this section. Strapping is widely used in sports and has various applications. Strapping can be used to provide support and stability and provide some proprioceptive feedback to the joint. Strapping is also widely used to inhibit or to activate various muscle groups, useful in the rehabilitation process for PWH with muscle injuries or improve muscle balancing RG7204 between agonist and antagonist [38]. PNF uses isometric

and isotonic muscle contractions to improve range of movement and strength. It also uses functional sequential movements which can improve sequencing of muscle firing patterns. Short term use of splints especially in the acute or subacute post-bleed period can be beneficial in preventing recurrence of an injury. During gait reeducation, splints can limit the impact on various joints or muscles. find more Prolonged injudicious use, however, can result in muscle atrophy and or joint stiffness. Orthotics can improve the biomechanical alignment of joints, improving stability, and aid in injury prevention. Caution needs to be exercised when prescribing rigid orthoses, such as knee ankle foot orthoses (KAFOs), as they can cause muscle atrophy and stiffness. They can put undue pressure on other joints and may make them more susceptible to injury. Serial casting with plaster of Paris (POP) or thermoplastic material can be used to gradually stretch and improve ROM in joints and muscles. However, these may require close follow-up in order for them to be effective and to prevent complications of casting.

1A). Given his abdominal

discomfort and an abnormal hepatic Doppler study, he proceeded to an abdominal angiogram, which revealed a severe stenosis between the donor and recipient cava with minimal hepatic venous (HV) outflow (Fig. 2). The intercaval anastomosis was crossed with a guide wire and a balloon dilatation to 8 mm was performed resulting in markedly improved hepatic venous outflow (Fig. 3). Two months later the patient’s dyspnea had completely resolved and PaO2 on room air had risen to 89 mmHg (Fig. 4). A repeat 99mTcMAA lung perfusion scan (Fig. 1B) revealed no significant brain uptake and thus confirmed resolution of HPS. To our knowledge, the recurrence of HPS in an adult NCPH patient post-OLT has not been reported. HPS has been reported to recur posttransplantation in the context of serious graft disease or cirrhosis.[2] In our case it redeveloped in the absence of any evidence BI6727 of graft

damage, suggesting that the hemodynamic alterations associated with impairment Selleckchem Ipatasertib of hepatic outflow were solely responsible. While HV outlet obstruction is an unusual cause of HPS, the syndrome has been described in individuals with IVC obstruction with amelioration of hypoxia on restoration of flow.[3] Why the disease occurs in only a minority of cirrhosis patients and only occasionally in patients with NCPH is uncertain. However, this presumably reflects an underlying “susceptibility” in those who develop the syndrome which is absent in most patients. What factors govern this susceptibility is as yet unknown. The redevelopment of clinically significant

HPS in our patient many years posttransplant after apparent complete resolution of the syndrome shows that this susceptibility selleck products persists for life and that it cannot be related to liver disease per se or some host susceptibility factor within the liver. “
“A 62-year-old male was referred to our department after a segmental resection of the small bowel due to a spontaneous perforation 3 months earlier. He complained of anorexia, fever and abdominal pain. The patient had lost 10 kg of body mass within the last 3 months. He had no history of celiac disease or chronic diarrhea. On admission, the patient was in poor general condition with severe cachexia. The abdomen was distended and a large firm mass was palpable in the left midabdomen. The peripheral lymph nodes were not enlarged. Laboratory tests revealed pancytopenia and hypoalbuminemia. Liver function tests, serum lactate dehydrogenase and β2-microglobulin were mildly elevated. Computed tomography (CT) scan of the abdomen showed multiple cystic lesions with fat-fluid levels within the mesentery (arrows) and a hypotrophic spleen (Figure 1A). Magnetic resonance imaging (MRI) demonstrated several intra-abdominal cysts (arrows) along the mesentery (Figure 1B) and multiple bone lesions suggesting metastases. On surgical exploration, the mesenteric lymph nodes were cystic and 1–10 cm in size (Figure 2).

The role of PKC-delta was evaluated using a PKC activator (PMA, 100 nM), PKC inhibitors see more (5 uM chelethryine, 100 uM H-7 or 0.5 uM calphostin), siRNA to PKC delta, and wild type (WT) or constitutively active (CA) PKC delta plasmid constructs. Activation of PKC

delta was monitored by immunoblotting for Thr 505 phosphorylation (HUH7Ntcp) or for total PKC delta in the mitochondria (rat hepatocytes). Phosphorylation of JNK and Akt and the amount of total BIM were determined by immunoblotting. RESULTS: GCDC treatment increased total PKC delta expression in rat hepatocyte mitochondria by 1.70 +/- 0.22 fold and induced a 5.71 +/-1.2 fold increase in the phosphorylation of PKC delta in HUH7-Ntcp cells. Within 2 hrs GCDC induced apoptosis in 16% +/- 4.5 % of rat hepatocytes and 10.5% +/- 2.3% of HUH7-Ntcp cells and resulted CP-673451 in cleavage of caspase 3.Treatment of hepatocytes or HUH7-Ntcp cells with PMA decreased GCDC apoptosis by 71% +/-3.4% and 92% +/1 6.7%, respectively. In rat hepatocytes, PKC inhibitors increased GCDC induced apoptosis from 24% to 92%. Knock down of PKC delta increased GCDC apoptosis by 2.7 +/-0.98

fold, while WT- and CA-PKC-delta decreased apoptosis by 35% +/2.5% and 54% +/- 5.6%, respectively. Knock down of PKC delta increased pro-apoptotic JNK phosphorylation and total BIM levels by 2.4 and 2.3 times, respectively and decreased anti-apoptotic Akt phosphorylation by 52% +/-6.7%. GCDC apoptosis was accompanied by mitochondrial translocation of BIM and knock down

of BIM decreased GCDC induced apoptosis in HUH7-Ntcp cells by 51% +/- find more 3.6%. CONCLUSION: Taken together, these results suggest that activation of PKC-delta by GCDC induces a cytoprotective pathway that results in inhibition of JNK activation, activation of Akt and down-regulation of BIM. Disclosures: The following people have nothing to disclose: Cynthia R. Webster, Mohammed S. Anwer “
“Background and Aim:  Gallstone formation is characterized by the abnormal regulation of cholesterol trafficking and solubilization. The prevalence of gallstone disease (GSD) differs between ethnic groups sharing the common environment. These differences can be explained by a genetic predisposition to gallstone formation. Studies have identified single nucleotide polymorphisms (SNP) D19H and T400K in the cholesterol transporter gene ATP-binding cassette, subfamily G, member 8 (ABCG8) in patients with cholesterol gallstones. The aim of this study was to analyze the relationship between D19H and T400K polymorphisms in the ABCG8 gene and GSD in an Indian population, and the effects of these polymorphisms on cholesterol levels in sera and bile. Methods:  A total of 226 patients with GSD were analyzed for their lipid profile in plasma and bile.

The role of PKC-delta was evaluated using a PKC activator (PMA, 100 nM), PKC inhibitors selleck compound (5 uM chelethryine, 100 uM H-7 or 0.5 uM calphostin), siRNA to PKC delta, and wild type (WT) or constitutively active (CA) PKC delta plasmid constructs. Activation of PKC

delta was monitored by immunoblotting for Thr 505 phosphorylation (HUH7Ntcp) or for total PKC delta in the mitochondria (rat hepatocytes). Phosphorylation of JNK and Akt and the amount of total BIM were determined by immunoblotting. RESULTS: GCDC treatment increased total PKC delta expression in rat hepatocyte mitochondria by 1.70 +/- 0.22 fold and induced a 5.71 +/-1.2 fold increase in the phosphorylation of PKC delta in HUH7-Ntcp cells. Within 2 hrs GCDC induced apoptosis in 16% +/- 4.5 % of rat hepatocytes and 10.5% +/- 2.3% of HUH7-Ntcp cells and resulted CT99021 purchase in cleavage of caspase 3.Treatment of hepatocytes or HUH7-Ntcp cells with PMA decreased GCDC apoptosis by 71% +/-3.4% and 92% +/1 6.7%, respectively. In rat hepatocytes, PKC inhibitors increased GCDC induced apoptosis from 24% to 92%. Knock down of PKC delta increased GCDC apoptosis by 2.7 +/-0.98

fold, while WT- and CA-PKC-delta decreased apoptosis by 35% +/2.5% and 54% +/- 5.6%, respectively. Knock down of PKC delta increased pro-apoptotic JNK phosphorylation and total BIM levels by 2.4 and 2.3 times, respectively and decreased anti-apoptotic Akt phosphorylation by 52% +/-6.7%. GCDC apoptosis was accompanied by mitochondrial translocation of BIM and knock down

of BIM decreased GCDC induced apoptosis in HUH7-Ntcp cells by 51% +/- find more 3.6%. CONCLUSION: Taken together, these results suggest that activation of PKC-delta by GCDC induces a cytoprotective pathway that results in inhibition of JNK activation, activation of Akt and down-regulation of BIM. Disclosures: The following people have nothing to disclose: Cynthia R. Webster, Mohammed S. Anwer “
“Background and Aim:  Gallstone formation is characterized by the abnormal regulation of cholesterol trafficking and solubilization. The prevalence of gallstone disease (GSD) differs between ethnic groups sharing the common environment. These differences can be explained by a genetic predisposition to gallstone formation. Studies have identified single nucleotide polymorphisms (SNP) D19H and T400K in the cholesterol transporter gene ATP-binding cassette, subfamily G, member 8 (ABCG8) in patients with cholesterol gallstones. The aim of this study was to analyze the relationship between D19H and T400K polymorphisms in the ABCG8 gene and GSD in an Indian population, and the effects of these polymorphisms on cholesterol levels in sera and bile. Methods:  A total of 226 patients with GSD were analyzed for their lipid profile in plasma and bile.

Materials and Methods: A prospectively maintained database of all pancreatic cases requiring surgery was used to identify cases and the notes reviewed. Patients with infected pancreatic necrosis are managed in a step-up fashion according to a set protocol as described by Connor et al1. Results: 25 patients with a median age of 58 (22–79) and M : F = 13:12, underwent MARPN for infected necrosis in a four year period. The main aetiology was gallstones (68%) Each patient underwent debridement a median of 3 (1–7) times. 22 patients required ITU support with a median stay of 26 days (1–99) Median APACHE II score prior to ITU admission was 14 (8–27). Surgery related complications included bleeding (2), gastro-pancreatic

SAR245409 in vitro fistula,(1) enteric fistula (1) and colonic perforation (1). Pancreatitis related morbidity included pneumonia, renal failure, MODS and diabetes. 2 patients subsequently required laparotomy for complications. Overall in hospital mortality was 40% and median length of stay was 76 days.

Table 1: Mortality and APACHE II score by referral method Referred from other hospital? Died Alive % mortality Mean APACHE II score (p = 0.0715) Yes 8 8 50 18 No 2 Selleck Wnt inhibitor 7 22 13 Discussion: Infected pancreatic necrosis can be managed using MARPN with an acceptable mortality rate provided patients are referred expediently. Though not statistically significant due to small numbers, it was apparent in our series that patients

transferred from other centres were sicker and had higher mortality (table 1), though exact reasons for this were not clear. Further education of non-specialists managing pancreatitis in other centres may improve outcomes for these patients. 1. Connor S, Ghaneh P, Raraty M, et al. Minimally invasive retroperitoneal pancreatic necrosectomy. Dig Surg. 2003;20:270–277. 2. Raraty M, Halloran C, Dodd S et al. Minimal Access Retroperitoneal Pancreatic Necrosectomy: selleck Improvement in Morbidity and Mortality With a Less Invasive Approach. Ann Surg 2010;251: 787–793 Y HUANG,1 G MACQUILLAN,1 L ADAMS,1,2 G GARAS,1 LJ MOU,1 A MITCHELL,1 L DELRIVIERE,1 GP JEFFREY1,2 1WA Liver Transplantation Service (WALTS), Sir Charles Gairdner Hospital, 2School of Medicine, University of Western Australia, Perth Introduction: The geographic isolation of Perth, WA has resulted in a significant number of recipients who received a donor liver transported from other states and New Zealand. The transport distances vary from 2132 km (1324 miles) to 5345 km (3321 miles). This allows a unique opportunity to evaluate the effect of long distance aircraft transport of donor livers on post-transplant (OLT) outcomes. Methods: 285 patients who had an OLT performed by the WALTS based at Sir Charles Gairdner Hospital, Perth from 1992 to 2012 were analysed. Donor and recipient clinical information was extracted from the WALTS database.

g., <2 m), probably because of discrepancies between the bathymetric models and the GPS and QFP location fixes. Short surfacing times (>30 s for a GPS fix and ~5 s for a QFP fix) fail to generate a location fix, because the GPS radio frequency is attenuated by salt water and the GPS units turn off to save battery life whenever the saltwater sensor on the unit is submerged,

such as when the dugong is diving (>3 m) or swimming Wnt inhibitor rapidly, causing the unit to be dragged underwater (Marsh and Rathbun 1990). Hence the subset of data we examined might be biased if some habitats (e.g., shallow) or behaviors (e.g., resting) had higher fix rates than others (e.g., deep water or traveling fast). The subsets of dive measurements were recorded around the time GPS or QFP fixes were generated, and often a location was fixed every 1 h at most, even with a 20 min satellite buy NVP-LDE225 transmission interval. In contrast the

TDRs continued to collect dive measurements every 1 or 2 s over the deployment periods. Thus we compared the distributions of the dive depths from the subsets associated with fixes and those not associated with fixes using contingency tests to determine how representative the fix-associated subsets of dive data were of the entire dive data set. We used all available dive data associated with fixes. For the nonfix associated depth data, we randomly selected four sets of one-day dive data from each of the nine dugongs (four × one-day dive data × nine animals). Statistical tests were performed separately for data from Moreton and Hervey Bays. Depth records were categorized into five bins: 0 m to <5 m, 5 m to <10 m, 10 m

to <15 m, 15 m to <20 m, and ≥20 m. For the Hervey Bay data, the last two categories were combined due to small sample sizes. We examined the effects of the following three categorical variables on the proportions of time that the tracked dugongs spent in the two detection zones (0–1.5 m and 0–2.5 m): (1) water depth: 2 m to <5 m, 5 m to <10 m, 10 m to <15 m, 15 m to <20 m, 20 m check details to <25 m, and ≥25 m; (2) tidal conditions: flow and ebb tides; and (3) habitat types: seagrass meadows and offshore waters. For analysis of the detection zone 0–1.5 m, we excluded dive data from water depth ≤1.5 m because a dugong in this depth range was assumed to be fully available for detection even if it was on the seafloor (Pollock et al. 2006). The next shallowest water depth we examined was 2 m because the TDR resolution was 0.5 m. The shallowest category for the detection zone 0–2.5 m was 3 to <5 m for the same reason. In water ≥5 m deep, we grouped water depths into intervals of 5 m up to 25 m. The 5 m interval ensured that all animals were sufficiently represented in each bin. For the offshore waters, 35 m was our data limit with all animals represented, however, the limit from the seagrass data set was 25 m.

No such selleck chemicals llc difference was found for birds and mammals. Second, the relative proportions of presumably more palatable and presumably less palatable prey differed. The relative proportions of mice and voles (the latter eaten more frequently) and the

relative proportions of soricomorphs and rodents (the latter eaten more frequently) were different. Finally, small prey items (i.e. invertebrates) were recorded incompletely for the brought-home method. Overall, the prey-brought-home method underrepresented small prey and underestimated the predation rate for cats, whereas the prey-eaten method was less likely to record unpalatable prey. We thus recommend to combine these two methods to obtain fuller and truer assessment of cat predation. “
“Rare and elusive species are seldom the first choice of model for the study of ecological questions, yet rarity and elusiveness often emerge from ecological processes. One of these processes is interspecific killing, the most extreme form of interference competition among carnivores. Subdominant species can avoid falling victim to other carnivores through spatial and/or temporal separation. The smallest carnivore species, including

members of the Mustelidae, are typically the most threatened by other predators but are also exceedingly challenging to study in the wild. As a consequence, we have only limited knowledge of how the most at-risk members of carnivore communities deal with being both hunters and hunted. We explored whether activity and space use of a little-known small carnivore, click here selleck compound the Altai mountain weasel Mustela altaica, reflect the activity and distribution of its main prey, pika Ochotona sp., and two sympatric predators, the stone marten Martes foina and the red fox Vulpes vulpes. Spatial and temporal patterns of photographic captures in Pakistan’s northern mountains suggest that weasels may cope with being both predator and prey by frequenting areas used by pikas while exhibiting

diurnal activity that contrasts with that of the mostly nocturnal/crepuscular stone marten and red fox. Camera trap studies are now common and are staged in many different ecosystems. The data yielded offer an opportunity not only to fill knowledge gaps concerning less-studied species but also to non-invasively test ecological hypotheses linked with rarity and elusiveness. “
“Survival and consequent implications for population dynamics in the subtropical Striped Frog Hypsiboas leptolineatus was studied for 1 year in the southern Brazilian state of Paraná. By means of capture-marking-recapture, we estimated survival and capture probabilities in an open population. A total of 583 captures of 374 individuals, comprising 96% male (n = 353) and 4% females (n = 21), resulted in daily survival estimates ranging from 0.808 to 0.998 day−1.

6 The viral proteins Tamoxifen HBx and NS5 have been shown to bind and inhibit the tumor suppressor p53.7 The inactivation of p53 by these viral proteins is believed to be a major contributing event in the formation of HCCs.8 Furthermore, somatic mutations or deletion of TP53 are also common molecular events in human liver cancer.9 In addition to TP53 mutations, alterations in the transforming growth factor-beta (TGF-β) signaling pathway are commonly observed in HCC. TGF-β is a secreted cytokine that initiates downstream signals through binding to a heteromeric cell-surface receptor complex that consists of two transmembrane serine-threonine kinases, TGF-β receptor, type I (TGFBR1) and type II (TGFBR2). This activated

FK506 nmr receptor complex induces both Smad-dependent and Smad-independent signaling pathways.10 TGF-β has been found to be overexpressed in 40% of HCCs,11 whereas Tgfbr2 has been shown to be down-regulated in 37%-70% of tumors.12, 13 In the liver, TGF-β has been shown to play both tumor-suppressive and tumor-promoting roles.14, 15 This paradoxical role of TGF-β in cancer is believed to be a consequence of the context dependence of the TGF-β signaling pathway on tumor cells. Among other factors, the concurrent gene alterations present in a tumor cell can influence whether TGF-β signaling has primarily an oncogenic or tumor-suppressive role.

Thus, it is important to determine cooperative effects of specific gene mutations on the TGF-β signaling pathway in order to determine what effect therapies directed at the TGF-β pathway may have on cancers carrying this website specific mutations that affect the pathway output.16 Studies from in vitro systems have revealed that p53 and TGF-β can cooperate to regulate a number of cellular responses.17 p53 physically interacts with Smad2 and Smad3 in a TGF-β-dependent manner.18 In mouse embryonic fibroblasts, p53 is required for TGF-β-mediated growth arrest and in Xenopus defective embryonic development results from impaired TGF-β/Activin/Nodal signaling caused by the loss of p53.18 Although p53 and Smads function as transcription factors that bind distinct promoter sequences, they have been shown to

coordinately regulate a number of target genes. For example, at the Mix.2 promoter, p53 binding is required for expression and is believed to help stabilize a larger complex consisting of Smad2, Smad4, and FAST1.18 Additionally, the repression of alpha-fetoprotein (AFP), a clinical marker of HCC, depends on the interaction between Smads, p53, and the corepressors, SnoN and mSin3A.19, 20 Therefore, the importance of the relationship between the p53/TGF-β signaling pathways in regulating the transcriptional response of cells to various stimuli has been established, but the relevance to in vivo HCC formation remains to be determined. Thus, we developed a mouse model system to investigate if p53 and Tgfbr2 cooperate in vivo to affect HCC formation.

10 Cotransplantation with HSC resulted in long-term survival in >60% islet allografts without requirement of immunosuppression, which was associated with enhanced CD8+ T-cell apoptosis, as well as a marked increase in Foxp3+ regulatory T (Treg) cells (increased from ∼10% in controls to ∼40% CD4+ cells). HSC eliminate antigen-specific activated CD8+ cells through the B7-H1 pathway; however, the mechanisms involved in Treg cells expansion remain unclear.11, 12 There is accumulating data suggesting that peripheral Treg cells are generated from naïve T cells by stimulation of particular subsets of antigen-presenting cells (APC) in lymph nodes (LN).13, 14 Even though HSC can modestly expand naturally existing Treg

cells in vitro,15 it is unlikely that HSC can directly induce large amounts of Treg cells in vivo because cotransplanted GFP-HSC do not show an ability to migrate to draining (d) LN (unpubl. data). We hypothesize that induction of Treg cells may be GDC-0941 molecular weight mediated by cells PLX4032 solubility dmso other than HSC. Myeloid-derived

suppressor cells (MDSC) were initially identified in cancer patients and contribute to cancer evasion from immune surveillance. They contain heterogeneous myeloid cell populations, but share some common characteristics: immature phenotype, inability to differentiate into mature myeloid cells, high expression of arginase 1, and a high potential to suppress immune response.16 In this study we provide both in vivo and selleck chemical in vitro evidence that HSC preferentially induce MDSC. These

effects are dependent on the interferon gamma (IFN-γ) signaling pathway in HSC and are mediated by soluble factor(s). APC, antigen-presenting cells; BM, bone marrow; CFSE, carboxyfluorescein diacetate succinimidyl ester; DC, dendritic cells; ELISA, enzyme-linked immunosorbent assay; Gr-1, granulocyte-differentiation antigen-1; H-MC, HSC-conditioned myeloid cells; hpf, high-power field; HSC, hepatic stellate cells; LN, lymph node; MLR, mixed leukocyte reaction; mAb, monoclonal antibody; MDSC, myeloid-derived suppressor cells; NPC, nonparenchymal cells; POD, postoperative day; qPCR, quantitative polymerase chain reaction; SMA, smooth muscle actin; Treg, T regulatory; WT, wildtype. Male C57BL/6J (B6, H2b), BALB/c (H2d), C3H (H2k), IFN-γR1−/−, granulocyte colony-stimulating factor (G-CSF)−/−, granulocyte-macrophage colony-stimulating factor (GM-CSF)−/−, and OT-I and OT-II TCR transgenic mice were purchased from Jackson Laboratory (Bar Harbor, ME). The mice with chicken oval albumin (OVA) specific expression on hepatocytes (OVA-HEP) were provided by Dr. Marion Peters (University of California, San Francisco, CA). B7-H1 knockout mice were provided by Dr. Lieping Chen (Johns Hopkins University Medical School, Baltimore, MD). All animals were maintained and used following National Institutes of Health (NIH) guidelines. (Please see Materials and Methods in Supporting Data for further details.